AIS
IBB icon

Accurate Investment Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Accurate Investment Solutions’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-46
Closed -$5K – 176
2020
Q1 		$5K Sell
46
-4
-8% -$461 ﹤0.01% 337
2019
Q4 		$6K Hold
50
– – ﹤0.01% 326
2019
Q3 		$5K Hold
50
– – ﹤0.01% 270
2019
Q2 		$5K Hold
50
– – ﹤0.01% 271
2019
Q1 		$6K Buy
+50
New +$5.48K ﹤0.01% 248

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Accurate Investment Solutions's IBB Position: Q2 2020 in Review

Accurate Investment Solutions sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 46 shares — an estimated $5K sold.

Accurate Investment Solutions first reported a position in IBB in Q1 2019 and held it in 5 quarters. The position peaked at $6K in Q4 2019. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

  • Accurate Investment Solutions reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
  • Accurate Investment Solutions sold 46 iShares Biotechnology ETF shares in Q2 2020, an estimated $5K.
  • Accurate Investment Solutions first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 5 quarters.
  • Accurate Investment Solutions's iShares Biotechnology ETF position peaked at $6K in Q4 2019.
  • 766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Accurate Investment Solutions's 13F filing for Q2 2020.